نتائج البحث من 91 إلى 100 من أصل 1846 لعبارة anti-TNF drugs
Stem cell therapy has emerged as a new paradigm of treatment in the field of CHD with promising results. Cardiac regeneration has been the focus of acquired, ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Translational Neuropathology Melissa E Murray.
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... treatment until disease progression or 2 years since treatment ... anti-PD(L)1 ...
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
... anti-T-cell immunoglobulin and ITM domain (TIGIT) ... Chemotherapy drugs, such as capecitabine and ... Giving atezolizumab with usual treatment may work better than ...
Drugs used in chemotherapy, such as cisplatin and ... anti-HER2 therapies, such as trastuzumab ... A Study to Evaluate the Safety, Tolerability, Pharmacokinetics ...
Neurobiology of Neurodegenerative Diseases Wilfried O Rossoll.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.